Articles dans des revues avec comité de lecture (15)
1.
Draguet, F., Dubois, N., Bouland, C., Pieters, K., Bron, D., Meuleman, N., Stamatopoulos, B., & Lagneaux, L. (2023). Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells. Cancers, 15(11), 2901. doi:10.3390/cancers151129012.
Stamatopoulos, B., Smith, T. B., Crompot, E., Pieters, K., Clifford, R., Mraz, M., Robbe, P., Burns, A., Timbs, A., Bruce, D., Hillmen, P., Meuleman, N., Mineur, P., Firescu, R., Maerevoet, M., De Wilde, V., Efira, A., Philippé, J., Verhasselt, B., Offner, F., Sims, D., Heger, A., Dreau, H., & Schuh, A. (2018). The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results of a multicenter study. Clinical cancer research. doi:10.1158/1078-0432.CCR-18-01333.
Crompot, E., Van Damme, M., Pieters, K., Vermeersch, M., Perez-Morga, D., Mineur, P., Maerevoet, M., Meuleman, N., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2017). Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B-cells from apoptosis, enhance their migration and induce gene expression modifications. Haematologica, 102(9), 1594-1604. doi:10.3324/haematol.2016.1633374.
Najar, M., Raicevic, G., Andre, T., Fayyad Kazan, H., Pieters, K., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2016). Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties. Cytotherapy, 18(3), 320-335. doi:10.1016/j.jcyt.2015.11.0135.
de la Kethulle de Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton, S. B., Coppee, F., Lagneaux, L., & Belayew, A. (2015). The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow. Stem cells and development, 24(22), 2674-2686. doi:10.1089/scd.2014.05756.
Busser, H., Najar, M., Raicevic, G., Pieters, K., Velez Pombo, R., Philippart, P., Meuleman, N., Bron, D., & Lagneaux, L. (2015). Isolation and characterization of human mesenchymal stromal cells subpopulations: comparison of bone marrow and adipose tissue. Stem cells and development. doi:10.1089/scd.2015.01727.
Andre, T., Najar, M., Stamatopoulos, B., Pieters, K., Pradier, O., Bron, D., Meuleman, N., & Lagneaux, L. (2015). Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells. Cancer immunology and immunotherapy, 64(2), 213-224. doi:10.1007/s00262-014-1623-y8.
Crompot, E., Van Damme, M., Duvillier, H., Pieters, K., Vermeesch, M., Perez-Morga, D., Meuleman, N., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2015). Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control. PloS one, 10(5), e0127209. doi:10.1371/journal.pone.01272099.
Busser, H., De Bruyn, C., Urbain, F., Najar, M., Pieters, K., Raicevic, G., Meuleman, N., Bron, D., & Lagneaux, L. (2014). Isolation of adipose derived stromal cells without enzymatic treatment: expansion, phenotypical and functional characterization. Stem cells and development. doi:10.1089/scd.2014.007110.
Philippart, P., Meuleman, N., Stamatopoulos, B., Najar, M., Pieters, K., De Bruyn, C., Bron, D., & Lagneaux, L. (2013). In Vivo Production of Mesenchymal Stromal Cells After Injection of Autologous Platelet-Rich Plasma Activated by Recombinant Human Soluble Tissue Factor in the Bone Marrow of Healthy Volunteers. Tissue Engineering. Part A. Tissue Engineering. doi:10.1089/ten.TEA.2013.024411.
Andre, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Pieters, K., Bron, D., & Lagneaux, L. (2013). Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells. PloS one, 8(3), e59756. doi:10.1371/journal.pone.005975612.
Raicevic, G., Najar, M., Pieters, K., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2012). Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Engineering. Part A. Tissue Engineering, 18(13-14), 1410-1418. doi:10.1089/ten.TEA.2011.0434